Now that all the debts have been converted to common shares (except for warrants at higher price), there should be interest in raising the stock price. Perhaps, we might even see some pumping by outside paid interests. It is also clear now why the there was downward pressure in the last few weeks.
Also, the outstanding shares, fully diluted, will be close to 900m. In order to affect only 1/10 reverse split to get to $4/share, the company has to have a valuation of about 360m.
(1)
(1)
Amarantus Bioscience Holdings (AMBS) Stock Research Links